Why is Valiant Laborato falling/rising?

As of 05-Jun, Valiant Laboratories Ltd is currently priced at 107.00, reflecting an increase of 1.0 (0.94%). The stock is trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive short-term trend. However, there has been a significant decline in investor participation, with delivery volume dropping by 64.77% compared to the 5-day average. Despite recent positive financial results, including a higher PAT of Rs 3.05 cr and record net sales of Rs 57.79 cr, the stock faces challenges due to weak long-term fundamentals, including a negative return on equity and declining sales growth. Additionally, while institutional investors have increased their stake, the stock is technically in a mildly bearish range, which may contribute to investor caution.
In the broader market context, Valiant Laboratories has outperformed the benchmark Sensex in the short term, with a 1-week return of 2.69% compared to the benchmark's decline of 0.23%. However, the stock has significantly underperformed over the past year, with a return of -21.03% against the Sensex's gain of 9.49%. This stark contrast highlights the stock's struggles despite some recent positive movements, suggesting that while there may be short-term gains, the long-term outlook remains concerning due to fundamental weaknesses and overall market performance.